Wednesday, April 30th, 2025

Renounceable Non-Underwritten Rights Issue of GS Holdings Limited – Key Investor Details

Key Points and Investor Actions:

  1. Rights Issue Overview:

    • GS Holdings Limited is offering a renounceable non-underwritten rights issue of up to 570,888,708 new ordinary shares at an issue price of S$0.015 per Rights Share. The ratio is two (2) Rights Shares for every one (1) existing ordinary share held as of the record date.
  2. Discount Information:

    • The issue price represents an 11.76% discount to the volume-weighted average price of S$0.017.
  3. Dates to Note:

    • Record Date: 11 September 2024, 5:00 p.m.
    • Last Date for Acceptance and Payment for Rights Shares: 30 September 2024.
    • Trading of Rights Shares Commencement: 8 October 2024.
  4. Actions for Shareholders:

    • Eligible shareholders can subscribe for their provisional allotments by the deadline of 30 September 2024.
    • Excess Rights Shares can also be applied for during the rights issue period.
  5. Allotment and Listing:

    • Rights Shares have been allotted and listed on SGX-ST on 8 October 2024, with trading commencing the same day.

Special Notes for Investors:

  • Foreign shareholders will not be entitled to participate in this rights issue unless they have provided an address in Singapore prior to the record date.
  • The Rights Shares rank pari passu with existing shares, except for any dividends or distributions declared before the rights issue.

Investors should be aware of these timelines and ensure their actions align with the key dates to maximize their benefits from the rights issue.

Notice of Annual General Meeting for Japfa Ltd

JAPFA Ltd’s Annual General Meeting: Dividends, Board Changes, and Fundraising Potential Key Highlights: The company is proposing a final one-tier tax-exempt dividend of 1.0 Singapore cent per ordinary share for the financial year ended...

17LIVE Group Proposes Major ESOP Expansion and Share Buyback Amid Revenue Decline: Key Shareholder Concerns Addressed

17LIVE’s Strategic Moves: Share Buybacks and ESOP Amendments Aim to Boost Shareholder Value 17LIVE’s Strategic Moves: Share Buybacks and ESOP Amendments Aim to Boost Shareholder Value 17LIVE Group Limited has released a detailed response...

Meta Health Limited Announces Renounceable Non-Underwritten Rights Issue to Raise S$1.58 Million

Meta Health Announces Rights Issue to Raise \$1.43M: Key Details for Shareholders Meta Health Announces Rights Issue to Raise \$1.43M: Key Details for Shareholders Meta Health Limited, a Singapore-based healthcare company, has announced its...